Blog

Categories

Balancing R&D for Disease X and common illnesses Infectious Diseases Vaccines Patrice Hugo, Ph.D. Balancing R&D for Disease X and common illnesses
Stakeholders from across the industry, including biopharmaceutical companies, governments, and non-profit organizations, are rethinking their pandemic readiness in light of the COVID-19 pandemic,...
 The New Generation of Vaccine Development for RSV Vaccines Default Author The New Generation of Vaccine Development for RSV
This year, the theme for World Immunization Week is “Protected Together, #VaccinesWork.” This theme brings to heart and mind the significant efforts of those who have developed life-saving...
 Laboratory Expertise for Early Bactericidal Activity (EBA) Studies Infectious Diseases Vaccines Ayaskant Pany, MD Laboratory Expertise for Early Bactericidal Activity (EBA) Studies
Authors: Dr. Ayaskant Pany and Sorika Van NiekerkRead somewhere recently: “What is the biggest constraint for tuberculosis (TB) clinical trials? RESOURCES!” This is so true not only in the...
 Vaccines in the Fight against Malaria Vaccines Default Author Vaccines in the Fight against Malaria
The theme for this year’s World Immunization Week, “#VaccinesWork”, rings true for the many diseases from which vaccines are protecting people of all ages across the globe. Yet, there are more...
 A CRO lab perspective on Ebola vaccine development Central Laboratories End-to-End Services Default Author A CRO lab perspective on Ebola vaccine development
This month, during World Immunization Week (April 24-30, 2017), we recognize immunizations as one of the world’s most important and effective health interventions, responsible for saving countless...
 What Does the Global Tuberculosis Biopharmaceutical Market Need to Grow? Infectious Diseases Vaccines Ayaskant Pany, MD What Does the Global Tuberculosis Biopharmaceutical Market Need to Grow?
Despite significant annual variation in research funding and global funding totals that fall far short of the field’s reported needs, the global market in tuberculosis (TB) diagnostics and treatments...
 A Super Battle Against Superbugs: Developing an Effective Drug-Resistant Tuberculosis Research Strategy Infectious Diseases Vaccines Ayaskant Pany, MD A Super Battle Against Superbugs: Developing an Effective Drug-Resistant Tuberculosis Research Strategy
When most people think of emerging threats to public health, tuberculosis (TB) is unlikely to rise to the forefront of their minds. After all, TB has a long history and has been a well-known global...
 Vaccines for Ebola Central Laboratories Vaccines Default Author Vaccines for Ebola
The 2014 Ebola crisis unfolded like a Hollywood movie, with gruesome deaths, tragic stories, and global panic about its potential spread. Ebola had never spread so far or fast in the known history of...
 Waging War of TB Central Laboratories Infectious Diseases Ayaskant Pany, MD Waging War of TB
Despite the fact that tuberculosis (TB) has been curable, it has become a global epidemic that impacts more people every year than HIV/AIDS. The millions of TB patients worldwide suffer from...